Search Results 2031-2040 of 16407 for Chronic Lymphocytic Leukemia
The purpose of this study is to collect and analyze neuroimaging, genetic markers, and clinical presentations and progressions of chronic traumatic ...
Elective rotations in pulmonary hypertension, thoracic surgery, cardiovascular surgery, and ECMO ICU, interstitial lung disease clinic, chronic obstructive lung ...
Ustekinumab is an approved drug for the treatment of moderate and severe CD. Participation eligibility. Participant eligibility includes age, gender, type and ...
Clinical Trials · Early Intensive Versus Escalation Approaches for Relapsing-Remitting Multiple Sclerosis Long Term Extension · More about research at Mayo Clinic.
His research group additionally looked at the Glasgow Coma Scale and its validity as a marker of severe head injury and the need for prehospital intubation.
Mayo Clinic in Minnesota has begun treating liver metastases using hepatic artery infusion pump chemotherapy. This intensified, targeted chemotherapy ...
Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...
Hematology — Learn about innovative diagnosis and ... Acute Leukemia/Myelodysplasia Group · Adolescent ... Chronic Lymphoproliferative Disorders Group ...
About this study. Thirteen APOLLO Clinical Centers (CCs), or Networks, will prospectively enroll eligible living kidney donors and recipients of kidneys ...
Int J Chronic Dis. 2020; 2020:4928648 Epub 2020 ... diagnosis? A multi ... Fungal infections in leukemia patients: how do we prevent and treat them?
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.